These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7989408)

  • 1. Correlation between nephrotoxicity and pharmacokinetic parameters of gentamicin.
    el-Sayed YM
    J Clin Pharm Ther; 1994 Aug; 19(4):267-71. PubMed ID: 7989408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
    Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
    Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gentamicin disposition and effect on development of renal function in the very low birth weight infant.
    Landers S; Berry PL; Kearns GL; Kaplan SL; Rudolph AJ
    Dev Pharmacol Ther; 1984; 7(5):285-302. PubMed ID: 6383749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of a change in gentamicin clearance as an early predictor of gentamicin-induced nephrotoxicity.
    Kirkpatrick CM; Duffull SB; Begg EJ; Frampton C
    Ther Drug Monit; 2003 Oct; 25(5):623-30. PubMed ID: 14508386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gentamicin disposition in young and elderly patients with various degrees of renal function.
    Matzke GR; Jameson JJ; Halstenson CE
    J Clin Pharmacol; 1987 Mar; 27(3):216-20. PubMed ID: 3680577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of intraperitoneal gentamicin in peritoneal dialysis patients with peritonitis (GIPD study).
    Varghese JM; Roberts JA; Wallis SC; Boots RJ; Healy H; Fassett RG; Lipman J; Ranganathan D
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1249-56. PubMed ID: 22700884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gentamicin and renal function: lessons from 15 years' experience of a pharmacokinetic service for extended interval dosing of gentamicin.
    Plajer SM; Chin PK; Vella-Brincat JW; Buffery PJ; Begg EJ
    Ther Drug Monit; 2015 Feb; 37(1):98-103. PubMed ID: 24943063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with creatinine clearance changes following gentamicin therapy.
    Prince RA; Ling MH; Hepler CD; Rainville EC; Kealey GP; Donta ST; LeFrock JL; Kowalsky SF
    Am J Hosp Pharm; 1980 Nov; 37(11):1489-95. PubMed ID: 7211851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An approach to forecast aminoglycoside-related nephrotoxicity from routinely collected clinical data.
    Kubota K; Suganuma T; Sasaki T; Ishizaki T
    Ther Drug Monit; 1988; 10(4):410-20. PubMed ID: 3201525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pathological evaluation of gentamicin in cats given a small intravenous dose repeatedly for five days.
    Jernigan AD; Hatch RC; Brown J; Crowell WA
    Can J Vet Res; 1988 Apr; 52(2):177-80. PubMed ID: 3370552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is endogenous creatinine clearance a sound basis for estimation of elimination half life of gentamicin?].
    Rameis H; Hitzenberger G; Jaschek I; Graninger W
    Dtsch Med Wochenschr; 1980 Nov; 105(47):1650-4. PubMed ID: 7439047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic factors associated with gentamicin nephrotoxicity in rabbits.
    Frame PT; Phair JP; Watanakunakorn C; Bannister TW
    J Infect Dis; 1977 Jun; 135(6):952-6. PubMed ID: 864290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
    Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
    Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gentamicin pharmacokinetics and nephrotoxicity in naturally acquired and experimentally induced disease in dogs.
    Frazier DL; Aucoin DP; Riviere JE
    J Am Vet Med Assoc; 1988 Jan; 192(1):57-63. PubMed ID: 3343180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple once-daily dose pharmacokinetics and renal safety of gentamicin in dogs.
    Albarellos G; Montoya L; Ambros L; Kreil V; Hallu R; Rebuelto M
    J Vet Pharmacol Ther; 2004 Feb; 27(1):21-5. PubMed ID: 14995962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gentamicin pharmacokinetics in adults with bacterial endocarditis.
    Rosell-Rovira ML; Pou-Clavé L; García-Beltran L; Pascual-Mostaza C
    Am J Hosp Pharm; 1994 Jun; 51(11):1429-32. PubMed ID: 7942877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.
    Kirkpatrick CM; Duffull SB; Begg EJ
    Br J Clin Pharmacol; 1999 Jun; 47(6):637-43. PubMed ID: 10383541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded gentamicin volume of distribution in critically ill adult patients receiving total parenteral nutrition.
    Ronchera-Oms CL; Tormo C; Ordovás JP; Abad J; Jiménez NV
    J Clin Pharm Ther; 1995 Oct; 20(5):253-8. PubMed ID: 8576291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of postnatal age on gentamicin pharmacokinetics in neonates.
    Knight JA; Davis EM; Manouilov K; Hoie EB
    Pharmacotherapy; 2003 Aug; 23(8):992-6. PubMed ID: 12921246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single intravenous and multiple dose pharmacokinetics of gentamicin in healthy llamas.
    Lackey MN; Belknap EB; Greco DS; Fettman MJ
    Am J Vet Res; 1996 Aug; 57(8):1193-9. PubMed ID: 8836374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.